Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Stake as of Sep 30, 2026 · Filed Oct 13, 2026
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
Written by software from the filings listed below · Oct 13, 2026
2 more points, with the facts they come from, are in OQRO Pro.
Sign up freeUndefined
Compared with the manager's prior 13F
—
NaN
For the same quarter
Insider selling
Traded Nov 11 · filed the same day
A major shareholder of Veradermics told the SEC about a plan to sell $37.6M of Veradermics shares around Nov 11, 2026. The shares were not acquired as compensation.
Fund moves
2 tracked managers disclosed the same change for Q2 2026. From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Fund moves
4 tracked managers disclosed the same change for Q2 2026. From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
